The Mechanisms of Action of Tumor Treating Fields

Author:

Moser Justin C.12ORCID,Salvador Ellaine3ORCID,Deniz Karina4,Swanson Kenneth5,Tuszynski Jack6ORCID,Carlson Kristen W.7,Karanam Narasimha Kumar8,Patel Chirag B.910ORCID,Story Michael8ORCID,Lou Emil4ORCID,Hagemann Carsten3ORCID

Affiliation:

1. 1HonorHealth Research and Innovation Institute, Scottsdale, Arizona.

2. 2Department of Medicine, University of Arizona College of Medicine- Phoenix, Phoenix, Arizona.

3. 3Section Experimental Neurosurgery, Department of Neurosurgery, University of Würzburg, Würzburg, Germany.

4. 4Department of Medicine, Division of Hematology Oncology and Transplant, University of Minnesota, Minneapolis, Minnesota.

5. 5Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts.

6. 6Department of Physics, University of Alberta, Edmonton, Alberta, Canada.

7. 7Department of Neurosurgery, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts.

8. 8Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.

9. 9Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston Texas.

10. 10Neuroscience and Cancer Biology Graduate Programs, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences.

Abstract

Abstract Tumor treating fields (TTFields), a new modality of cancer treatment, are electric fields transmitted transdermally to tumors. The FDA has approved TTFields for the treatment of glioblastoma multiforme and mesothelioma, and they are currently under study in many other cancer types. While antimitotic effects were the first recognized biological anticancer activity of TTFields, data have shown that tumor treating fields achieve their anticancer effects through multiple mechanisms of action. TTFields therefore have the ability to be useful for many cancer types in combination with many different treatment modalities. Here, we review the current understanding of TTFields and their mechanisms of action.

Funder

HonorHealth

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3